Talumate Tablet (Talniflumeate)

Adult dose

Adults: Administer 370 mg orally 3 times daily as talniflumate. In severe cases, administer 740 mg per dose. Adjust the dose as appropriate according to age and symptoms.

This medication may increase the risk of gastrointestinal bleeding for those who consume alcohol regularly, more than three glasses a day, so it should be discussed with a doctor or pharmacist. This medication can affect the cardiovascular system and may increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke, so patients with a history of cardiovascular diseases or risk factors need to be especially cautious. As it can cause serious gastrointestinal disorders such as gastrointestinal bleeding, ulcers, perforation, etc., elderly patients or those with a history of gastrointestinal diseases should be particularly careful when taking this medication. This drug should not be taken by individuals with a peptic ulcer or an allergy to any components of this medication, patients who have had hypersensitivity reactions to aspirin or other non-steroidal anti-inflammatory drugs, or those with certain genetic metabolic disorders. Patients with liver or kidney dysfunction, or allergies to certain pigment components should use this medication cautiously. Mild reactions such as nausea or vomiting may occur on taking it, and prolonged use may lead to gastrointestinal adverse reactions such as gastrointestinal bleeding or ulcers. This medication should be used at the lowest effective dose for the shortest duration possible, and regular blood tests, as well as liver and kidney function tests, are essential for long-term use. Patients with hypertension or heart failure should closely monitor blood pressure and fluid status while taking this medication, and those with reduced kidney function should also be given special caution. This drug can interact with other anti-inflammatory pain relievers or certain medications, so it is essential to inform your healthcare provider if you are taking other medications. During pregnancy, especially in the later stages, it may pose risks to the fetus, so it should be avoided, and safety is not established during breastfeeding, requiring caution. It should not be administered to children under the age of 12, and the elderly should be especially careful to take the minimum dose due to the risk of adverse reactions. Finally, this medication should be kept out of the reach of children and should not be transferred to other containers for safety.

• Gastrointestinal bleeding
• cardiovascular thromboembolic reactions
• myocardial infarction
• stroke
• gastrointestinal hemorrhage
• peptic ulcer
• perforation
• nausea
• vomiting
• jaundice

This medication should be stored in a sealed container to prevent air from entering and at room temperature between 1°C and 30°C. Storing it this way can help maintain the effectiveness of the medication for a longer time.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle